Policies / Policies from 2018

Policies from 2018

Policies with publication year 2018.

Basic Healthcare Provision Fund Operations Manual

Ministry of Health

Nigeria2018HealthOther

This operations manual underscores and assures the focus of the Basic Healthcare Provision Fund on current health priorities: reproductive, maternal, child, adolescent health and nutrition, non-communicable diseases screening and emergency services (road traffic injuries i.e. RTIs).

Nigeria Essential Medicines List (Sixth Edition)

Ministry of Health, World Health Organization, Clinton Health Access Initiative

Nigeria2018HealthOther

This manual lists essential medicines that include analgesics, antipyretics and non-steroidal anti-inflammatory medicines, anti-convulsant, anaesthetics, antidotes, anti-infective medicines, anti-migraine medicines, among others.

Second National Strategic Health Development Plan: 2018-2022

Health

Nigeria2018HealthOther

This document outlines the framework for the development of the health sector for the period 2018 to 2022. The strategy is focused on mobilizing resources for the health sector and collaboration and coordination between stakeholders for the development of the health sector.

NAFDAC Drug Evaluation & Research (DER) Directorate Good Manufacturing Practice Guidelines for Cosmetics Products 2018

Ministry of Industry, Trade and Investment, National Agency for Food and Drug Administration and Control

Nigeria2018HealthOther

These cosmetic Good Manufacturing Practice (GMP) guidelines are for the manufacture, storage and shipment of cosmetic products. The primary objective of the guidelines is to ensure that products are consistently manufactured in conformance with quality standards. It is concerned with all aspects of production and quality control.

NAFDAC Registration & Regulatory Affairs (R & R) Directorate Guidelines on Variations to a Registered Pharmaceutical Product

Ministry of Health, National Agency for food and Drug Administration and Control

Nigeria2018HealthOther

This guidance document is technically and structurally inspired by the World Health Organisation�s variation guideline on the details of the various categories of variations to the terms of marketing authorizations for medicinal products for human use and veterinary medicinal products. The objectives of these guidelines are to assist applicants with the classification of changes made to the quality part of a registered Finished Pharmaceutical Product (FPP) and provide guidance on the technical and other general data requirements to support changes to the quality attributes of the Active Pharmaceutical Ingredient (API) or FPP.

Page 38 of 59

Showing 10 of 586 policies